Cassidy Bio Ltd.
Biomed — Stage: R&D. Est: 2024. Tags: Artificial Intelligence, Biotechnology, Deep Tech, Genomics, Guide RNA, Life Sciences, MedTech, Pharmaceuticals, Therapeutics. Cassidy Bio's platform addresses the challenges of genome editing by combining experimental data with artificial intelligence that learns from laboratory experiments. This allows for more precise design of drug components, making the development of gene drugs more predictable and clinically reliable. The company's technology aims to enable the creation of tailored treatments for cancer and metabolic liver diseases and to create an infrastructure that enables the development of gene drugs on a large scale.. Web: https://www.cassidybio.com